Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Is the ARS issue affected by current market problems

I know that was the prevailing logic 2 weeks ago, but when you look at the comparatively huge 30% pps drop in price since the end of August, something seems rotten in Denmark. With the majority of our cash tied up in the ARS vehicles, I'm wondering if something has changed over these last 2 weeks to the previous position of "valuable but illiquid" that would account for this drop in price.

When you lose 30% of your value in 2 weeks, there is obviously something that someone knows or expects to be negative. On the surface it doesn't seem like it is the USPTO process, or the M&A Deals, or management and BOD instability, or status quo lack of visibilty, ie. nothing seems to be different today than it was on 9/1 except the overall market issues, and the idea that PTSC wants to increase the Authorized (mind you not the outstanding) shares. Since the increase in Authorized shares means nothing....YET...I'm wondering if the issues lies in something in PTSC's makeup that is really affected by the market dynamics currently going on. The overall market seems to be in a situation much worse than PTSC's situation, yet PTSC is down nearly 3-fold compared to the overall market over the last 2 weeks. I'm just wondering if there's some impairment to the ARS assets due to this recent round of collapses and bailouts that hasn't yet come to the forefont.

Share
New Message
Please login to post a reply